Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85K Buy
67
+46
+219% +$1.02K ﹤0.01% 3145
2026
Q1
$307 Hold
21
﹤0.01% 3351
2025
Q4
$265 Sell
21
-37
-64% -$546 ﹤0.01% 3279
2025
Q3
$892 Hold
58
﹤0.01% 3114
2025
Q2
$912 Sell
58
-675
-92% -$10.2K ﹤0.01% 3039
2025
Q1
$14K Buy
733
+622
+560% +$13.6K ﹤0.01% 2227
2024
Q4
$2.65K Hold
111
﹤0.01% 2786
2024
Q3
$3.11K Hold
111
﹤0.01% 2706
2024
Q2
$2.9K Sell
111
-9
-8% -$187 ﹤0.01% 2662
2024
Q1
$2.62K Buy
120
+9
+8% +$193 ﹤0.01% 2730
2023
Q4
$2.58K Hold
111
﹤0.01% 2700
2023
Q3
$2.19K Hold
111
﹤0.01% 2748
2023
Q2
$2.52K Hold
111
﹤0.01% 2742
2023
Q1
$2.18K Sell
111
-17
-13% -$326 ﹤0.01% 2780
2022
Q4
$2.2K Buy
+128
New +$2.27K ﹤0.01% 2788

Other funds holding RXO

SignatureFD's RXO Position: Q2 2026 in Review

SignatureFD increased its RXO (RXO) stake by 219% in Q2 2026, buying an estimated $1.02K and bringing the position to 67 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3145.

SignatureFD first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $14K in Q1 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • SignatureFD held 67 shares of RXO worth $1.85K as of Q2 2026.
  • SignatureFD bought 46 RXO shares in Q2 2026, an estimated $1.02K.
  • RXO made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3145 holding.
  • SignatureFD first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • SignatureFD's RXO position peaked at $14K in Q1 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.